More on AVBP

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)

Upcoming Events

- Earnings (11/18/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

ArriVent BioPharma (NQ:AVBP)
Delayed: 16.66 -0.13 (0.77%)
Prev. Close $16.79  
Open$16.86 
52 Wk High$ 
52 Wk Low$ 
Day High$17.23 
Day Low$16.49 
P/E N/A  
EPS$ 
Volume1,334,063 


Oct 16, 2026 06:07 AM ArriVent BioPharma (AVBP) PT Raised to $27 at Jefferies
Oct 13, 2026 04:01 PM Form SCHEDULE 13G ArriVent BioPharma, Inc. Filed by: Vivo Opportunity Fund Holdings, L.P.
Oct 13, 2026 06:03 AM Form 8-K ArriVent BioPharma, Inc. For: Oct 12
Oct 12, 2026 04:03 PM ArriVent doses first patient in Phase 1 trial of ADC ARR-002
Oct 12, 2026 04:01 PM ArriVent Announces First Patient Dosed with Novel Tetravalent MUC16/NaPi2b Dual Target ADC, ARR-002
Oct 8, 2026 06:40 PM Form SCHEDULE 13D/A ArriVent BioPharma, Inc. Filed by: ORBIMED ADVISORS LLC
Oct 8, 2026 06:59 AM ArriVent BioPharma (AVBP) PT Lowered to $27 at H.C. Wainwright
Oct 7, 2026 07:33 AM ArriVent BioPharma (AVBP) PT Lowered to $18 at Guggenheim
Oct 7, 2026 07:13 AM ArriVent BioPharma (AVBP) PT Lowered to $18 at Truist Securities
Oct 7, 2026 05:03 AM ArriVent BioPharma (AVBP) PT Lowered to $29 at BTIG
View All Articles

Entities mentioned with AVBP

View All Entities